Kenneth C. Cundy, SVP, Preclinical Development at XENOPORT INC (XNPT), sold 2,800 shares at $26.94 ($74K) on 2009-01-02, disclosed to the SEC on 2009-01-06.
Scheduled sale ($74k) by SVP, Preclinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.92 | 100 | $3K | 3.5% |
| 2 | $25.97 | 100 | $3K | 3.5% |
| 3 | $25.98 | 100 | $3K | 3.5% |
| 4 | $26.09 | 100 | $3K | 3.5% |
| 5 | $26.10 | 100 | $3K | 3.5% |
| 6 | $26.13 | 200 |
| $5K |
| 7.0% |
| 7 | $26.14 | 100 | $3K | 3.5% |
| 8 | $26.15 | 100 | $3K | 3.5% |
| 9 | $26.16 | 200 | $5K | 7.0% |
| 10 | $26.18 | 100 | $3K | 3.5% |
| 11 | $26.33 | 100 | $3K | 3.5% |
| 12 | $26.47 | 100 | $3K | 3.6% |
| 13 | $26.53 | 8 | $212 | 0.3% |
| 14 | $26.53 | 92 | $2K | 3.3% |
| 15 | $26.60 | 100 | $3K | 3.6% |
| 16 | $26.68 | 100 | $3K | 3.6% |
| 17 | $26.88 | 100 | $3K | 3.6% |
| 18 | $26.94 | 100 | $3K | 3.6% |
| 19 | $26.97 | 100 | $3K | 3.6% |
| 20 | $26.98 | 100 | $3K | 3.6% |
| 21 | $26.99 | 100 | $3K | 3.6% |
| 22 | $27.00 | 100 | $3K | 3.6% |
| 23 | $27.02 | 200 | $5K | 7.3% |
| 24 | $27.05 | 100 | $3K | 3.6% |
| 25 | $27.22 | 100 | $3K | 3.7% |
| 26 | $27.35 | 100 | $3K | 3.7% |
| Total | $26.54 avg | 2,800 | $74K | 100% |
| Filing → |
| CWBR | SELL | 2020-08-10 | $19K | — | Filing → |
| CWBR | SELL | 2020-06-17 | $24K | — | Filing → |
| CWBR | SELL | 2020-05-18 | $26K | — | Filing → |